Webinars and Podcasts
Updating a Software Model to Estimate the Cost and Shelf Life Implications of New Platelet Technologies
An overview of the development of a cost model showing pathogen reduction’s (PR) potential operational efficiencies and total budget impact as compared to other guidance strategies.
Laura T. Pizzi, PharmD, MPH
Director, Health Outcomes, Policy, and Economics (HOPE) Program Professor, Department of Pharmacy Practice, Ernest Mario School of Pharmacy Professor, Department of Health Behavior, Society, and Policy, Rutgers School of Public Health